Office Of Public Affairs
Utah Diabetes Center Studying Whether Omega-3 Fatty Acid Can Prevent Type 1 Diabetes in Newborn Babies
Jan 28, 2008 12:00 PM
The Utah Diabetes Center at University Health Care is screening pregnant women in their third trimester and infants up to 5 months old for a study testing whether an omega-3 fatty acid found in some foods can prevent Type 1 diabetes.
The Utah Diabetes Center is one of nine centers nationwide participating in the Nutritional Intervention to Prevent Type 1 Diabetes Pilot Trial, or NIP for short. The goal is to intervene in the disease process before it begins in those babies most likely to acquire Type 1 diabetes later in life. Babies in utero and up to 5 months old whose mother, father, brother, sister, half-sister or half-brother has Type 1 diabetes are eligible for the study. Screening consists of a simple blood test. Babies who qualify will receive free testing and medical monitoring by diabetes researchers.
The NIP study will help researchers learn more about Docosahexaenoic acid, or DHA, an omega-3 fatty acid found in some foods, such as pumpkin seeds, coldwater fish, soybeans, walnuts, and eggs. Previous research has identified an association between omega-3 fatty acids and decreased risk for Type 1 diabetes in children. NIP is a pilot study, which if successful, may develop into a larger, definitive study. The study is sponsored by Type 1 Diabetes TrialNet, a global network of researchers funded by the National Institutes of Health and dedicated to the prevention, early detection, and treatment of Type 1 diabetes.
For more information about the NIP study at the Utah Diabetes Center, contact Eric Garcia at (801) 587-3972.
# # #
Public Relations Specialist , Office of Public Affairs
Pediatric Research Coordinator , Utah Diabetes Center
Visit our News Archive for a complete list of previous News.